Secunderabad Chronicle

Bipolar Depression Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – AbbVie, Cellon Pharma

 Breaking News
  • No posts were found

Bipolar Depression Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – AbbVie, Cellon Pharma

September 13
23:16 2023
Bipolar Depression Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies - AbbVie, Cellon Pharma
DelveInsight Business Research LLP
DelveInsight’s “Bipolar Depression Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Bipolar Depression, historical and forecasted epidemiology as well as the Bipolar Depression market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Bipolar Depression Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Bipolar Depression, historical and forecasted epidemiology as well as the Bipolar Depression market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Bipolar Depression Overview

Bipolar Depression, previously known as manic depressive illness or manic depression, is a mental disorder characterized by wide mood swings from high (manic) to low (depressed). In manic episodes, a person can be delighted, and irritable, and there is a marked increase in activity level, whereas, in depressive episodes, someone might feel sad, indifferent, or hopeless, in combination with a deficient activity level. Hypomanic episodes are also seen in patients, and it is a less severe form of mania. It is divided mainly into four subtypes BD-I, BD-II, cyclothymic disorder, and BD not otherwise specified (BD-NOS); the classification is based on the characteristics of mood swings.

Bipolar Depression Epidemiology Insights

  • In the year 2020, the total diagnosed prevalent case of Bipolar Disorder (Manic Depression) was 3,552,076 cases in the 7MM.

  • In the United States, the total number of diagnosed Bipolar Depression prevalent cases was 2,401,287 cases in the year 2020.

  • In the year 2020, the total diagnosed Bipolar Depression prevalent cases were 1,004,168 cases in EU-5.

  • In Japan, the total number of diagnosed Bipolar Depression prevalent cases was 146,621 cases in the year 2020.

Click here to learn more about the Bipolar Depression Market Landscape

 The Report Covers the Bipolar Depression Epidemiology Segmented by:

  • Bipolar Depression prevalent cases 

  • Bipolar Depression incident cases 

  • Bipolar Depression treatment cases 

  • Bipolar Depression diagnosed cases 

Bipolar Depression Market Outlook 

The Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder market trends by analyzing the impact of current Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Bipolar Depression Market

  • Intra-Cellular Therapies

  • NeuroRx

  • Sunovion (Sumitomo Dainippon Pharma)

  • Lundbeck/Otsuka Pharmaceutical

  • Celon Pharma

  • COMPASS Pathways

  • AbbVie

And many others 

 

Bipolar Depression Therapies Covered and Analyzed in the Report

  •  Brexpiprazole

  •  OSU6162

  •  Vortioxetine

  •  Valprote

  •  Olanzapine

And many others

Learn more about the Key Companies and Emerging Therapies in the Bipolar Depression Market

Table of Contents 

  1.  Key Insights 

  2.  Bipolar Depression Introduction 

  3.  Executive Summary of Bipolar Depression           

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  Bipolar Depression Emerging Therapies

  7.  Bipolar Depression Market Outlook

  8.  Market Access and Reimbursement of Therapies

  9.  Market Drivers 

  10.  Market Barriers 

  11.  Appendix

  12.  Report Methodology

  13.  DelveInsight Capabilities

  14.  Disclaimer

Learn about the detailed offerings of the report @ Bipolar Depression Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services